Future Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Information Exchange to Drive Value in Healthcare
AMSTERDAM, September 20, 2018 /PRNewswire/ -- Royal Philips [http://www.philips.com ] (NYSE: PHG) (AEX: PHIA), a global leader in health technology, today released a new Future Health Index (FHI) report "Moving data to the heart of health systems: Increasing vital technology adoption to make value-based healthcare a reality [https://www.futurehealthindex.com/report/2018/part/2 ] ." The research focused on two technology enablers that have the potential to advance integration, and enable data to be used more effectively. Digital identity tools, such as Electronic Health Records (EHRs), based on standardized data and protocols that can be accessed, used and updated by care providers across the health continuum, can make the collection and exchange of healthcare data much easier. Data analytics and AI can mine that data for connections and insights that will benefit both healthcare professionals and patients. This ranges from the identification of health trends at the level of an entire population, to more precise diagnosis, treatment and after care for individual patients.
The latest FHI report identifies the following key recommendations for the way in which health data is collected, shared and used, in order for countries to meet their goals of driving better value in healthcare:
- Strike the right balance in data protection and (de)regulation - Foster adoption through education - only 47% of healthcare professionals surveyed and 24% of the general population felt knowledgeable about connected care technologies - Secure buy-in through co-creation of solutions together with healthcare professionals and the general population - Harmonize data collection and use practices - countries with universal EHRs have a higher Value Measure [https://www.philips.com/a-w/about/news/archive/standard/news/press/2018/20180614-philips-commissioned-future-health-index-outlines-journey-to-value-based-healthcare.html ] than countries without universal EHRs (47.29 on average vs 39.67), as well as higher average levels of trust (67.79 vs. 62.99)
"The Future Health Index's latest report [https://www.futurehealthindex.com/value-measure ] shows that the smooth exchange of health information is central to delivering better value in healthcare," said Jan Kimpen, Chief Medical Officer for Philips. "By connecting people, data and systems we can create a network that allows information to flow seamlessly across care providers, locations and systems. It is through data that the outcomes that define value are tracked, measured and improved. Yet, health systems around the world are still struggling to collect, organize, analyze and use health data in a meaningful way. The recommendations made in the FHI are designed to address these very challenges and provide actionable next steps that healthcare leaders can take to optimize the value provided by the digital tools they are investing in."
FHI is a research-based platform designed to help determine the readiness of countries to address global health challenges and build sustainable, fit-for-purpose national health systems. Using the real-life learning of experts in the field, and insights uncovered in research, the FHI provides actionable recommendations for the healthcare industry; particularly around the adoption and implementation of crucial digital tools that can deliver more affordable, integrated and sustainable care. A key finding of the FHI is that integrating connected care technology into health systems can accelerate countries along the path to value-based healthcare.
To download the Future Health Index 2018 report in its entirety, please visit: https://www.futurehealthindex.com/report/2018/part-2-moving-data-to-the-heart-of-health-systems . For additional Future Health Index related content, please visit! _https://www.futurehealthindex.com.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 75,000 employees with sales and services in more than 100 countries. News about Philips can be found at http://www.philips.com/newscenter .
For further information, please contact: Elena Calamo Specchia Philips Group Press Office Tel.: +31-6-25004735 E-mail: Elena.Calamo.Specchia@philips.com
SOURCE Royal Philips
Company Codes: EuronextAmsterdam:PHIA, NYSE:PHG, Bloomberg:PHG@US, Bloomberg:PHIA@NA, RICS:0LNG.L, RICS:PHG.N, ISIN:NL0000009538, ISIN:US5004723038